Description

2-[[(3R,4S)-3-[(4R)-2,2-Dimethyl-1,3-Dioxolan-4-Yl]-7,7-Dimethyl-2,6,8-Trioxabicyclo[3.3.0]Oct-4-Yl]Oxy]-N,n-Dimethyl-Ethanamine is a sophisticated chiral intermediate featuring a complex bicyclic acetal structure. This compound is of significant value in the synthesis of high-value, biologically active molecules, particularly within the pharmaceutical sector. It is primarily sought after by research institutions and manufacturers engaged in the development of novel therapeutics, including antiviral and anti-inflammatory agents.

Application

• Pharmaceutical Intermediate: A key chiral building block for the synthesis of complex drug candidates, especially nucleoside analogs and other bioactive molecules.
• Antiviral Drug Research: Used in the research and development of new antiviral compounds targeting specific viral enzymes.
• Asymmetric Synthesis: Serves as a valuable starting material or intermediate in stereoselective chemical reactions to introduce specific chiral centers.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies and lead optimization processes.
• Process Chemistry Development: Used for scaling up synthetic routes in pilot plants and commercial manufacturing of active pharmaceutical ingredients (APIs).
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and process development for pharmaceutical clients.

Basic Information

Product Name	2-[[(3R,4S)-3-[(4R)-2,2-Dimethyl-1,3-Dioxolan-4-Yl]-7,7-Dimethyl-2,6,8-Trioxabicyclo[3.3.0]Oct-4-Yl]Oxy]-N,n-Dimethyl-Ethanamine
CAS No.	67441-19-4
Molecular Formula	C16H29NO6
Molecular Weight	331.41 g/mol
Synonyms	N,N-Dimethyl-2-[[(3R,4S)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]oct-4-yl]oxy]ethanamine; (3R,4S)-4-[(2-Dimethylamino)ethoxy]-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]octane; 2-((3R,4S)-3-((4R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]octan-4-yloxy)-N,N-dimethylethanamine; Chiral Dioxolane-Bicyclic Acetal Intermediate
EINECS	Contact for details

Quality Control

Our 2-[[(3R,4S)-3-[(4R)-2,2-Dimethyl-1,3-Dioxolan-4-Yl]-7,7-Dimethyl-2,6,8-Trioxabicyclo[3.3.0]Oct-4-Yl]Oxy]-N,n-Dimethyl-Ethanamine is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including chiral purity verification, to meet the exacting standards required for pharmaceutical R&D and manufacturing. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting identity, purity, and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). The container should be kept tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.